Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Argos Therapeutics
4233 Technology Drive
Durham, NC 27704
Phone: 919-287-6300
www.argostherapeutics.com

Argos Therapeutics is a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis™ technology platform. Argos' most advanced product candidate AGS-003 has initiated a pivotal Phase 3 study for the treatment of mRCC, and the Company plans to have data from its Phase 2b study of AGS-004 for the treatment of HIV in the first half of 2014.

Key Contact
Name
Jeffrey D. Abbey
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
08/26/13 $42,500,000 Series E Aurora Funds
Caisse de depot et placement de Quebec
Forbion Capital Partners
Green Cross
Intersouth Partners
Lumira Capital
Morningside Group
Pharmstandard International
undisclosed
11/21/13 $17,500,000 Series E-1 Aurora Funds
Caisse de depot et placement de Quebec
Forbion Capital Partners
Green Cross
Intersouth Partners
Lumira Capital
Morningside Group
Pharmstandard International
undisclosed